Polymorphisms of human Estrogen Receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2071-2074

  Bergner, C C ^a   Krause, F S ^a   Zugor, V ^a   Rith, T ^a   Schrott, K M ^a   Endele, S ^a   Engehausen, D G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Estrogen receptor; Mutation screening; PC EW; PC OR; Prostate cancer

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENOMIC DNA; OLIGONUCLEOTIDE;

CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN ANALYSIS; SCREENING TEST; XENOTRANSPLANTATION;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICE; NEOPLASMS, HORMONE-DEPENDENT; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 34250741309     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Arbeitsgemeinschaft bevölkerungsbezogener Krebsregister in Deutschland & Robert-Koch-Institut: Krebs in Deutschland. 3. überarbeitete, aktualisierte Ausgabe. Saarbrücken, 2004.
3. Suzuki K, Takezawa Y, Suzuki T, Honma S and Yamanaka H: Synergistic effects of estrogen with androgen on the prostate - effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. Prostate 25: 169-176, 1994.
4. Suzuki K, Ito K, Suzuki T, Honma S and Yamanaka H: Synergistic effects of estrogen and androgen on the prostate: effects of estrogen on androgen- and estrogen-receptors, BrdU uptake, immunohistochemical study of AR, and response to antiandrogens. Prostate 26: 151-163, 1995.
5. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW and Damassa D: Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80: 1045-1053, 1998.
6. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M and Rajvir Dahiya M: Polymorphisms of estrogen receptor alpha in prostate cancer. Mol Carcinog 37: 202-208, 2003.
7. Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K and Yamanaka H: Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Cancer 98: 1411-1416, 2003.
8. Medeiros R,Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J and Lopees C: Steroid hormone genotypes ARStu1 and ER325 are linked to the progression of human prostate cancer. Cancer Gen Cytogen 141: 91-96, 2003.
9. Bardin A, Boulle N, Lazennec G, Vignon F and Pujol P: Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocrine-related Can 11: 537-551, 2004.
10. Ponglikitmongkol M, Green S and Chambon P: Genomic organization of the human estrogen receptor gene. EMBO J 7: 3385-3388, 1988.
11. Menasce LP, White G, Harrison GJ and Boyle JM: Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17: 263-265, 1993.
12. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M and Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocr Metab 82: 4258-4265, 1997.
13. Hoehn W, Wagner M, Riemann JF, Hermanek P, Williams E, Walther R and Schruffeer R: Prostatic adenocarcinoma PC-EW, a new human tumor line transplantable in nude mice. Prostate 5: 445-452, 1984.
14. Engehausen DG, Endele S, Krause FS, Rith T, Schrott KM and Akcetin Z: Polymorphisms in the human progesterone receptor (PGR) gene of two human prostate adenocarcinoma cell lines. Anticancer Res 25(3A): 1607-1609, 2005.
15. Engehausen DG, Krause FS, Fleischmann J, Akcetin Z, Schrott KM and Endele S: Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR. Anticancer Res 25(3A): 1611-1614, 2005.
16. Jiang M and Huhtaniemi I: Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol 39: 1603-1611, 2004.
17. Castagnetta LA, Miceli MD, Sorci CM, Pfeffer U, Farruggio O, Calabro M and Carruba G: Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinol 136: 2309-2319, 1995.
18. Modugno F, Weissfeld JL, Trump D, Zmuda J, Shea P, Cauley J and Ferell R: Allelic variants of aromatase and the androgen and estrogen receptors: Toward a multigenic model of prostate cancer risk. Clin Cancer Res 7: 3092-3096, 2001.
19. Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius M, Escary JL, Berthon P and Cussenot O: Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. European Urology 44: 487-490, 2003.
20. Jiang SY, Parker CJ and Jordan VC: A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens. Breast Cancer Res Treat 26: 139-147, 1993.
21. Knoblauch R and Garabedian MJ: Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol 19: 3748-3759, 1999.
22. Gold B, Kalush F, Bergeron A, Scott K, Mitra N, Wilson N, Ellis N, Huang H, Chen M, Lippert R, Halldorsson B, Woodworth B, White T, Clark AG, Pari F, Broder S, Dean M and Offit K: Estrogen receptor genotypes and haplotypes associated with breast cancer risk, Cancer Res 64: 8891-8900, 2004.